Atlas Trials

Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2

Clinical trial NCT03209869 · WITHDRAWN

Trial details

NCT number
NCT03209869
Sponsor
University of Wisconsin, Madison
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
NeuroblastomaRelapsed NeuroblastomaRecurrent NeuroblastomaOsteosarcoma
Start date
2018-03-12
Primary completion
2022-09-07
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.